Research
FORUM TRANSCRIPT

Ambu – Urology Portfolio & Customer Assessment – 17 January 2022

  • Multi Asset
  • Healthcare
  • Global
PREMIUM

Specialist

President at Allina Health System

Agenda

  • Competitive positioning of key players including Ambu (CSE: AMBU.B), Boston Scientific (NYSE: BSX), Verathon (NYSE: ROP) and Olympus (TYO: 7733)
  • Ambu's aScope 4 Cysto, its use case and key benefits
  • Continued trend towards single-use scopes including uptake expectations
  • Key decision criteria behind using single vs disposable scope, including key costs

Questions

For access to this and thousands of other Transcripts, request a free trial

Request A Demo